The Food and Drug Administration has issued a warning to women and their doctors about the health risks of using tests marketed for ovarian cancer screening. The agency says that because there is currently no reliable screening test for ovarian cancer, the use of these products may lead to a delay in preventative treatments for women who show no signs of ovarian cancer but who are still at risk of the disease.
Although ovarian cancer represents only 3% of cancer cases diagnosed among U.S. women, the disease causes more deaths than any other cancer affecting the female reproductive tract. Because the ovaries are less accessible than other parts of the female body where cancer may form – such as the breasts or cervix – most cases of ovarian cancer are only diagnosed when the cancer has spread to other parts of the body. As a result, ovarian cancer has a significantly higher mortality rate than other forms of cancer affecting women. About 64% of women who are diagnosed with ovarian cancer in the U.S. will die from the disease.
The FDA says that although there is currently no ovarian cancer screening test that can detect the disease without a high number of false positives, over the years, several companies have marketed screening tests for the disease. The agency cautions that the use of these tests could lead women and their doctors to make treatment decisions based on inaccurate results.
According to the FDA, some women who undergo ovarian cancer screening tests may receive test results that show signs of ovarian cancer even though the disease is not present. Women who receive these false positive results may undergo unnecessary additional tests or surgical procedures, which could lead to complications. In other cases, tests may show that ovarian cancer is not present for women who actually have the disease, leading to treatment delays that could have adverse health consequences.
The FDA is advising women to be aware of the unreliability of ovarian cancer screening tests currently on the market. Women at an increased risk of ovarian cancer – such as those who have the BRCA1 or BRCA2 genetic mutations – should talk with their doctor about how to reduce their risk of developing the disease.
Talcum Powder Products Linked to Ovarian Cancer Risk
Recent studies have shown that women who use talcum powder products may face an increased risk of developing ovarian cancer. The use of talcum powder products has also been associated with a higher risk of uterine cancer, also known as endometrial cancer. Hundreds of women who have been diagnosed with cancer after using talcum powder for feminine hygiene have filed lawsuits against Johnson & Johnson or other companies who manufacture talc products.
If you or a loved one has been diagnosed with ovarian cancer or uterine cancer after using baby powder or body powder products containing talc, you may be eligible to file a lawsuit against the manufacturer of these products. The first step in taking legal action is to speak with an attorney who has the experience in product liability cases to advise you regarding your legal rights.
The lawyers at Heygood, Orr & Pearson are currently representing dozens of women who were diagnosed with ovarian cancer after using Johnson’s Baby Powder, Shower to Shower, or other talcum powder products sold by Johnson & Johnson. Our attorneys have the experience, knowledge, and expertise with product liability litigation to handle claims on your behalf.
The attorneys at Heygood, Orr & Pearson have tried hundreds of lawsuits to verdict and reached settlements in hundreds more. Our law firm has the financial resources to handle product liability cases involving talcum baby powder or other dangerous products on behalf of our clients. In many cases, our firm has invested hundreds of thousands of dollars of our own money in order to take a case to trial.
For more information about the talcum powder lawsuits filed by Heygood, Orr & Pearson and to find out whether you may qualify to take legal action, contact our office by calling toll-free at 1-877-446-9001. You can also reach us by following this link to our free case evaluation form and answering a few brief questions about your case to get started.